Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Women's and Children's Health Research Seminar - Dr Sarah Donald

Prescription medicine use and safety during pregnancy in New Zealand – Dr Sarah Donald

For most prescription medicines available on the market, robust safety information about their use during pregnancy is limited because pregnant women are typically excluded from clinical drug trials. International studies have shown increasing use of prescription medicines during pregnancy over recent decades, making post-marketing safety studies focused on pregnant women vitally important. Retrospective cohort studies undertaken using routinely collected health data can be used to assess medicine safety during pregnancy.

In this presentation I will discuss some findings of my recent research into prescription medicine exposure during pregnancy in New Zealand, including the use of specific medicines known to carry increased risk of fetal harm (Category D/X medicines). I will also discuss the use of antidepressants during pregnancy, and highlight some potential safety issues associated with SSRI use.

Date Thursday, 7 May 2020
Time 1:00pm - 2:00pm
Audience Postgraduate Only,Staff Only
Event Category Health Sciences
Event Type Seminar
CampusDunedin
DepartmentWomen's and Children's Health (Dunedin)
LocationZoom (please email wch.research@otago.ac.nz for Zoom room)
CostFree
Contact NameSarah-Jane Robertson
Contact Emailwch.research@otago.ac.nz

Save this event